THERAPIES
-
The CHS pressures provinces to reimburse hemophilia B gene therapy
Montréal, December 17, 2025 – The Canadian Hemophilia Society (CHS) has written to the Provincial/Territorial Ministers of Health (excluding Quebec) to urge them to add...
-
The CHS urges provinces to accept CBS recommendation to introduce Altuviiio
Montréal, December 12, 2025 – In a letter dated December 10, the Canadian Hemophilia Society (CHS) urged the Provincial/Territorial Blood Liaison Committee (P/TBLC) to accept...
-
Update on novel therapies for hemophilia A and B
MONTRÉAL, September 19, 2025 – No announcements have been made over the summer on progress in gaining access to two novel hemophilia therapies. Altuviiio for...
-
WFH mobilizes global community to achieve milestone revisions to WHO EML
While this does not affect Canada directly, it is a major step forward for the international community and acknowledges what Canada is already doing in...
-
Reimbursement of Altuviiio recommended, but…
MONTRÉAL, July 3, 2025 – In June, both Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) released...